Logo image of IREN

IREN LTD (IREN) Stock Fundamental Analysis

NASDAQ:IREN - Nasdaq - AU0000185993 - Common Stock - Currency: USD

6.54  +0.24 (+3.81%)

After market: 6.5 -0.04 (-0.61%)

Fundamental Rating

3

IREN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 284 industry peers in the Software industry. IREN has a bad profitability rating. Also its financial health evaluation is rather negative. IREN is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

IREN had negative earnings in the past year.
In the past year IREN had a positive cash flow from operations.
IREN had negative earnings in each of the past 5 years.
Of the past 5 years IREN 4 years had a positive operating cash flow.
IREN Yearly Net Income VS EBIT VS OCF VS FCFIREN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -100M -200M -300M -400M

1.2 Ratios

The Return On Assets of IREN (-2.77%) is comparable to the rest of the industry.
IREN has a Return On Equity (-3.98%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -2.77%
ROE -3.98%
ROIC N/A
ROA(3y)-42.61%
ROA(5y)-38.24%
ROE(3y)-51.63%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IREN Yearly ROA, ROE, ROICIREN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 50 -50 100

1.3 Margins

IREN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IREN Yearly Profit, Operating, Gross MarginsIREN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -200 -400 -600

More info and screens

2

2. Health

2.1 Basic Checks

IREN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for IREN has been increased compared to 1 year ago.
IREN has a better debt/assets ratio than last year.
IREN Yearly Shares OutstandingIREN Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M 150M
IREN Yearly Total Debt VS Total AssetsIREN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

IREN has an Altman-Z score of 1.08. This is a bad value and indicates that IREN is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.08, IREN is in line with its industry, outperforming 40.35% of the companies in the same industry.
IREN has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
IREN's Debt to Equity ratio of 0.00 is fine compared to the rest of the industry. IREN outperforms 67.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.08
ROIC/WACCN/A
WACC11.14%
IREN Yearly LT Debt VS Equity VS FCFIREN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 0.94 indicates that IREN may have some problems paying its short term obligations.
IREN has a Current ratio of 0.94. This is in the lower half of the industry: IREN underperforms 77.54% of its industry peers.
A Quick Ratio of 0.94 indicates that IREN may have some problems paying its short term obligations.
With a Quick ratio value of 0.94, IREN is not doing good in the industry: 76.84% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.94
Quick Ratio 0.94
IREN Yearly Current Assets VS Current LiabilitesIREN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

7

3. Growth

3.1 Past

IREN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 90.75%, which is quite impressive.
Looking at the last year, IREN shows a very strong growth in Revenue. The Revenue has grown by 149.98%.
IREN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 188.02% yearly.
EPS 1Y (TTM)90.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%227.78%
Revenue 1Y (TTM)149.98%
Revenue growth 3Y188.02%
Revenue growth 5YN/A
Sales Q2Q%169.9%

3.2 Future

Based on estimates for the next years, IREN will show a very strong growth in Earnings Per Share. The EPS will grow by 206.14% on average per year.
The Revenue is expected to grow by 70.36% on average over the next years. This is a very strong growth
EPS Next Y653.84%
EPS Next 2Y508.55%
EPS Next 3Y206.14%
EPS Next 5YN/A
Revenue Next Year176.41%
Revenue Next 2Y123.25%
Revenue Next 3Y70.36%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
IREN Yearly Revenue VS EstimatesIREN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
IREN Yearly EPS VS EstimatesIREN Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 1 -1 -2 -3

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

IREN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
IREN is valuated cheaply with a Price/Forward Earnings ratio of 5.78.
97.54% of the companies in the same industry are more expensive than IREN, based on the Price/Forward Earnings ratio.
IREN is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.38, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 5.78
IREN Price Earnings VS Forward Price EarningsIREN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IREN Per share dataIREN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IREN's earnings are expected to grow with 206.14% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y508.55%
EPS Next 3Y206.14%

More info and screens

0

5. Dividend

5.1 Amount

IREN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IREN LTD

NASDAQ:IREN (4/25/2025, 8:16:11 PM)

After market: 6.5 -0.04 (-0.61%)

6.54

+0.24 (+3.81%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-12 2025-02-12/amc
Earnings (Next)05-07 2025-05-07/amc
Inst Owners45.49%
Inst Owner ChangeN/A
Ins Owners4.6%
Ins Owner ChangeN/A
Market Cap1.47B
Analysts83.33
Price Target21.55 (229.51%)
Short Float %9.87%
Short Ratio1.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)88.88%
Min EPS beat(2)-187.16%
Max EPS beat(2)364.93%
EPS beat(4)2
Avg EPS beat(4)-219.67%
Min EPS beat(4)-1085.5%
Max EPS beat(4)364.93%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.76%
Min Revenue beat(2)-6.94%
Max Revenue beat(2)1.42%
Revenue beat(4)2
Avg Revenue beat(4)-1.31%
Min Revenue beat(4)-6.94%
Max Revenue beat(4)3.47%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.04%
PT rev (3m)3.1%
EPS NQ rev (1m)-26.3%
EPS NQ rev (3m)15.22%
EPS NY rev (1m)-56.51%
EPS NY rev (3m)-9.27%
Revenue NQ rev (1m)-8.09%
Revenue NQ rev (3m)9.77%
Revenue NY rev (1m)-6.21%
Revenue NY rev (3m)-2.85%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 5.78
P/S 5.14
P/FCF N/A
P/OCF 18.05
P/B 1.14
P/tB 1.14
EV/EBITDA N/A
EPS(TTM)-0.33
EYN/A
EPS(NY)1.13
Fwd EY17.3%
FCF(TTM)-1.22
FCFYN/A
OCF(TTM)0.36
OCFY5.54%
SpS1.27
BVpS5.73
TBVpS5.73
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.77%
ROE -3.98%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-42.61%
ROA(5y)-38.24%
ROE(3y)-51.63%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 124.35%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.94
Quick Ratio 0.94
Altman-Z 1.08
F-Score5
WACC11.14%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)123.51%
Cap/Sales(5y)130.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)90.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%227.78%
EPS Next Y653.84%
EPS Next 2Y508.55%
EPS Next 3Y206.14%
EPS Next 5YN/A
Revenue 1Y (TTM)149.98%
Revenue growth 3Y188.02%
Revenue growth 5YN/A
Sales Q2Q%169.9%
Revenue Next Year176.41%
Revenue Next 2Y123.25%
Revenue Next 3Y70.36%
Revenue Next 5YN/A
EBIT growth 1Y44.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year5731.69%
EBIT Next 3Y360.33%
EBIT Next 5YN/A
FCF growth 1Y-140.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1304.73%
OCF growth 3Y210.56%
OCF growth 5YN/A